ProVise Management Group’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-5,390
Closed -$955K 294
2020
Q1
$955K Sell
5,390
-325
-6% -$61.2K 0.16% 132
2019
Q4
$1.09M Sell
5,715
-50
-0.9% -$9.02K 0.13% 141
2019
Q3
$970K Sell
5,765
-50
-0.9% -$8.15K 0.13% 146
2019
Q2
$974K Sell
5,815
-390
-6% -$54K 0.13% 150
2019
Q1
$908K Sell
6,205
-50
-0.8% -$7.25K 0.13% 147
2018
Q4
$836K Sell
6,255
-653
-9% -$107K 0.13% 151
2018
Q3
$1.32M Buy
6,908
+455
+7% +$83.6K 0.17% 130
2018
Q2
$9.4K Sell
6,453
-115
-2% -$18.5K 0.71% 44
2018
Q1
$1.11M Buy
6,568
+1,620
+33% +$272K 0.16% 136
2017
Q4
$810K Sell
4,948
-320
-6% -$57.4K 0.12% 156
2017
Q3
$1.08M Buy
5,268
+380
+8% +$88.4K 0.16% 145
2017
Q2
$1.19M Buy
4,888
+673
+16% +$158K 0.18% 133
2017
Q1
$1.01M Sell
4,215
-75
-2% -$17.5K 0.16% 141
2016
Q4
$901K Sell
4,290
-1,888
-31% -$391K 0.15% 151
2016
Q3
$1.42M Buy
6,178
+497
+9% +$121K 0.25% 118
2016
Q2
$1.31M Buy
+5,681
New +$1.31M 0.24% 115

Other funds holding AGN

ProVise Management Group's AGN Position: Q2 2020 in Review

ProVise Management Group sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 5,390 shares — an estimated $955K sold.

ProVise Management Group first reported a position in AGN in Q2 2016 and held it in 16 quarters. The position peaked at $1.42M in Q3 2016. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • ProVise Management Group reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • ProVise Management Group sold 5,390 Allergan plc shares in Q2 2020, an estimated $955K.
  • ProVise Management Group first reported a position in Allergan plc in Q2 2016 and held it in 16 quarters.
  • ProVise Management Group's Allergan plc position peaked at $1.42M in Q3 2016.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on ProVise Management Group's 13F filing for Q2 2020, filed 7 Aug 2020.